Table 1.
Different PNE and their anticancer mechanisms
P. nigrum plant part used | Sample used | Phytochemical/Compounds identified | Experimental model | IC50/Doses | Anticancer activity | Refs. |
---|---|---|---|---|---|---|
Dried fruit | Piperine-free P. nigrum fruits extract (PFPE) | n.d. |
In vitro: Breast cancer cells MCF-7 ZR-75-1 In vivo: NMU-treated female Sprague–Dawley mammary tumor rats |
MCF-7 (IC50 = 7.45 µg/mL), ZR-75-1 (IC50 = 7.45 µg/mL) (Dose = 100, 200, 400 mg/kg BW) |
Showed cancer prevention effects through ROS generation in vivo ↓ MMP-2, ↓MMP-9, ↓VEGF in vivo ↓ cancer cells proliferation activity by downregulated trancription factor, c-Myc in vitro |
[26] |
Dried fruits of black peppercorn |
Low piperine fractional P. nigrum extract (PFPE) |
Fifteen compounds were detected, and caryophyllene is a majority with 25% | In vivo: NMU-Induced Sprague–Dawley mammary tumor rats | (Dose = 200 mg/kg BW) |
↓ tumor progression ↑ the antitumor immunity by regulating the Th1/Th2/Treg |
[27] |
Dried fruits | Ethanolic extract rich in piperamides | Two major compounds of piperamides: piperine and piperyline |
In vitro: MCF-7 cells human breast cancer HT-29 human colorectal adenocarcinoma In vivo: Ehrlich ascites carcinoma-bearing mice |
MCF-7 human breast cancer cells (IC50 = 27.1 µg/mL), HT-29 colorectal adenocarcinoma (IC50 = 80.5 µg/mL) (Dose = 100 mg/kg BW) |
↓ cell proliferation in MCF-7 and HT-29 cells ↓ Tumor growth in vivo ↑ oxidative stress and apoptosis in vitro and in vivo ↑ Bax, ↑p53, Bcl-xL expression associated with apoptosis Tumor cell death related to oxidative stress in MCF-7 |
[28] |
Dried fruits | Aqueous water | P. nigrum tin oxide nanoparticle (SnO2 NPs) |
In vitro: human breast cancer cell MCF-7 In silico: EGFR receptor |
Dose = 75–200 µg/mL |
The favorable pharmacokinetics pharmacodynamics, and toxicity profiles of three promising compounds in silico Exhibited cytotoxicity against cancer cell in vitro |
[29] |
Dried unripe fruits of black pepper | Ethanolic extract | Phenolic group |
In vitro: Human colorectal cancer cells line HCT-116 HCT-15 HT-29 |
HCT-116: IC50 = 4.0 µg/mL, HCT-15: IC50 = 3.2 µg/mL, HT-29: IC50 = 7.9 µg/mL |
Inhibited cell proliferation | [33] |
Dried fruits | Methanol extract or dichloromethane extract | Alkaloids group |
In vitro: Human Breast cancer cells MCF-7 MDA-MB-231 MDA-MB-468 |
MCF-7: IC50 = 20.25 µg/mL, MDA-MB-231: IC50 = 22.37 µg/mL, MDA-MB-468: IC50 = 9.04 µg/mL |
Inhibited cell proliferation | [34] |
Unripe fruit | Ethanolic extract | Alkaloids gropus including piperine as a major constituent |
In vitro: PANC-1 human pancreatic cancer |
IC50 = 54.2 µg/mL |
Inhibited proliferation of PANC-1 through G0/G1 arrest ↓ protein levels of cell cycle regulators such as cyclin B1, cyclin D1, survivin, and Forkhead box M1 (FoxM1) ↓ cell migration and invation by decreasing FoxM1 protein level |
[35] |
Black pepper | Piperine enriched supercritical extract | Piperine is major compound was identified |
In vitro: MCF-7 human breast cancer cells In vivo: Balb/c mice-bearing Ehrlich Ascites Carcinoma (EAC) In silico: piperine binding to CDK2-Cyclin A and BCl-xL |
IC50 = 27.8 µg/mL Dose = 100 mg/kg BW |
↓ growth of breast cancer cell line MCF-7 that confirmed by interaction of piperine and protein targets CDK2-Cyclin A and BCl-xL ↑ apoptosis in MCF-7 breast cancer cells Inhibited tumor growth and showed lower levels of CDK2 and Cyclin A ↑ cell cycle arrest in G2/M phase in vivo ↑apoptotic cells and upregulated of pro apoptotic proteins (p53 and Bax) Hydrophobic interactions between piperine and residue Ser5 in CDK2; with residue Lys8 in Cyclin A; and Bcl-xL receptor |
[36] |
Dried young fruit | Ethanolic extract | n.d. | In vitro: Human breast cancer cells MCF‑7 | IC50 = 15.6 μg/mL |
Stimulated growth inhibition by increasing the G1 phase arrest and inhibiting cyclin D1 and NF‑κB Inhibited cell migration and reduced MMP-2, MMP 9, VEGFA, and ICAMP1 genes level Activated the ROS formation, increase caspase‑3 activity, and induced breast cancer cell death |
[30] |
Dried young fruit | Ethanolic extract | Phenolic and flavonoid contents including Piperine | In vitro: HeLa human cervical cancer cells | IC50 = 22.71 µg/mL |
Inhibited cell ploriferation and induced cell cycle arrest at G0/G1 phase Triggered apoptosis by inhibiting mitochondrial function and amplifying ROS production Suppressed cancer cells migration |
[31] |
Dried young fruit | Ethanolic extract | n.d. |
In vitro: Cholangiocarcinoma (CCA) /bile duct cancer KKU‑100 KKU‑M452 |
KKU-100 IC50 = 12.76 µg/mL, KKU-M452 IC50 = 38.32 µg/mL |
Inhibited cell viability and colony formation Decreased cell growth by cell cycle arrest at G0/G1 phase in KKU‑100 cells and S to G2/M phase in KKU‑M452 cells Induced apoptosis by decreasing mitochondrial function and increasing ROS production Suppressed cell migration |
[37] |
Black pepper seed | Aqueous extract | PNE silver nanoparticles (AgNPs): nineteen phytochemicals such as piperine, piperanine, ecuramide, pipecolic acid, betaine, salsolinol, hexadecanamide, oleamide, quinine |
In vitro: MDA-MB-231 human breast cancer PANC-1 human pancreatic cancer SKOV-3 human ovarian cancer PC-3 human prostate cancer HeLa human servical cancer |
MDA-MB-231: IC50 = 10 µg/mL PANC-1: IC50 = 10 µg/mL, SKOV-3: IC50 = 10 µg/mL PC-3: IC50 = 10 µg/mL HeLa: IC50 = 10 µg/mL |
Showed potent cytotoxicity against human cancer cell lines | [32] |
Black pepper seed | Aqueous extract | P. nigrum tin oxide nanoparticle (SnO2 NPs) |
In vitro: HCT-116 human colorectal cancer A549 human lung cancer |
HCT-116: IC50 = 0.165 µg/mL A549: IC50 = 0.135 µg/mL |
Demonstrated toxicity towards HCT 116 and A549 cells through the generation of ROS | [38] |
Black pepper seed | Ethanolic extract | Characterized piperine |
In vitro: Human metastatic melanoma SK-MEL 19 cells Intestinal adenocarcinoma malignant ascites AGP-01 Intestinal adenocarcinoma with an inactivated PIWIL1 gene AGP-01 PIWIL1−/− Neoplastic human pulmonary fibroblast cell line MCR5 |
SK-MEL 19: IC50 = 14.94 µg/mL AGP-01: IC50 = 13.52 µg/mL AGP-01 PIWIL1−/− IC50 = 21.26 µg/mL MCR5: IC50 = 14.17 µg/mL |
Induced cancer cells toxicity | [39] |
Dried fruit | Aqueous extract | P. nigrum AgNPS | In vitro: Human hepatocyte carcinoma HepG2 | IC50 = 4.98 µg/mL | Induced cancer cells toxicity | [40] |
Dried fruit | Aqueous extract | P. nigrum AgNPs |
In vitro: Human breast cancer cells MCF-7 Human larynx carcinoma cancer Hep-2 |
MCF-7: IC50 = 52 µg/mL Hep-2: IC50 = 54 µg/mL |
Induced cancer cells toxicity | [41] |
Dried black pepper |
Aqueous extract Methanolic extract |
Mainly piperine and alkyl amides |
In vitro: Human colon carcinoma HCT-116 Human breast cancer MCF-7 Human glioblastoma SF-268 Human lung carcinoma NCI-H460 |
HCT-116, MCF-7, SF-268, NCI-H460: IC50 = 200 µg/mL |
Induced cancer cells toxicity | [42] |
Dried fruit | CHCl3 extract | Alkaloids group (piperidine present) | In vitro: Human servical cancer HeLa | IC50 = 17.47 µg/mL | Induced cancer cells toxicity | [43] |
Dried fruit | Extract of methanol:water 1:1 | n.d. | In vivo: DMBA-induced skin tumorigenesis in Swiss albino mice | Dose = 150 mg/kg BW | Reduced the number of tumours in vivo test model | [44] |
Dried fruit | Ethanolic extract | n.d. |
In vitro: Murine Ehrlich Ascites Carcinoma EAC Murine melanoma-B16 Human servical cancer HeLa |
Murine Ehrlich Ascites Carcinoma EAC: IC50 = 8 µg/mL, Murine melanoma-B16: IC50 = 10 µg/mL, HeLa: IC50 = 17 µg/mL |
Induced cancer cells toxicity | [45] |
Dried fruit | n-hexane, chloroform, methanol and water extracts | Phenolic content | In vitro: Human cervical cancer cell line CaSki | IC50 = 36 µg/mL | Induced cancer cells toxicity | [46] |
Dried black pepper | Dichloromethane extract | Piperine free P. nigrum extract (PFPE), rich in pipercitine alkaloid and caryophyllene terpene |
In vitro: Human cholangiocarcinoma KKU-100 KKU-M213 KKU-M055 |
KKU 100: IC50 = 17.79 µg/mL, KKU M213: IC50 = 13.70 µg/mL, KKU M055: IC50 = 16.74 µg/mL |
Induced cancer cells toxicity | [47] |
Dried leaves | Methanolic extract |
Major: Tannin, flavonoid, steroid, polyphenol Minor: saponin, terpenoid, triterpenoid, alkaloid |
Human lung carcinoma A549 | Dose = 200–500 µg/mL | Induced cancer cells toxicity | [48] |
Dried root |
Extracts: petroleum ether and CHCl3 petroleum ether CHCl3 |
Alkaloids group | In vitro: Human leukemia cells HL 60 |
Petroleum ether: IC50 = 30 µg/mL, CHCl3: IC50 = 11.2 µg/mL, Combined: IC50 = 9.8 µg/mL |
Induced cancer cells toxicity | [49] |
Black pepper | Supercritical carbon dioxide extracts rich in piperine (SFE) | Piperine is major compound was identified |
In vivo: Balb/c mice bearing-Ehrlich ascites carcinoma cells (EAC) In silico: dGlutathione Peroxidase |
Dose = 100 mg/kg BW |
Inhibited EAC cells viability Enhanced EAC pro-oxidative status to induced oxidative stress Decreased glutatione peroxidase/GPx activity and GSH depletion The GPx-piperine poses hydrogen and hydrophobic bonds that contribute to inhibitionof GPx |
[50] |
n.d |
Five lead compounds: Clarkinol A Isodihydrofutoquinol B Burchellin Kadsurin B Lancifolin C |
In silico: Five lead compounds to Epidermal growth factor receptor (EGFR) |
Binding score: − 7.304 to − 6.342 kcal/mol |
Interacted well with EGFR receptor | [51] | |
n.d |
Campesterol Cholesterol Piperine Linoleic acid |
In silico: PPARγ, a glucose metabolism regulator factor that responsible for colorectal cancer |
Binding score: Campesterol (− 8.8 kcal/mol), Cholesterol (− 8.2 kcal/mol), Piperine (− 8.6 kcal/mol), Linoleic acid (− 6.2 kcal/mol) |
Interacted well with PPARγ target | [52] | |
Pure Piperine (97–98%) dissolved in DMSO | Piperine | HT-29 colon carcinoma cells | IC50 = 75–150 μM |
Inhibited HT-29 colon carcinoma cell proliferation by inducing G1 phase cell cycle arrest Triggered apoptosis by producing hydroxyl radical |
[53] | |
Dried roots | P. nigrum in petroleum ether and chloroform extracts | Several alkaloid groups such as: pellitorine, (E)-1-[30,40-(methylenedioxy) cinnamoyl] piperidine, 2,4-tetradecadienoic acid isobutyl amide, piperine, sylvamide, cepharadione A, piperolactam D and paprazine | HL60 (human promyelocytic leukaemia cells) | IC50 = 30 µg/mL | Inhibitory effect toward HL60 (human promyelocytic leukaemia cells) | [49] |
IC50: half-maximal inhibitory concentration; BW: body weight; PNE: P. nigrum extract; AgNPs: silver nanoparticles; PFPE: Piperine-free P.nigrum extract; PFPE-CH: Piperine-free P. nigrum extract combined with coconut oil and honey ROS; Reactive Oxygen Species: NMU: N-nitroso-N-methylurea; DMBA: 7:12-dimethylbenz[a]anthracene; n.d: not determined